WASHINGTON, D.C. – Scott Whitaker, president and CEO of AdvaMed, today released a statement on Georgia’s filing of a temporary restraining order against BD’s medical device sterilization plant in Covington, Ga.
Top News
Press Release | October 17, 2019
The Institute for Supply Management’s recently released September purchasing managers’ index – a key gauge of U.S. manufacturing strength – fell to its lowest reading in more than 10 years. The ISM index came in at 47.8% in September, the lowest since June 2009, and the second consecutive month of contraction.
Press Release | October 17, 2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), today sent a letter to U.S. President Donald J. Trump seeking his help as the association works with Congress to “eliminate once and for all” the medical device excise tax before it comes back into effect January 1, 2020.
Events
October
24
October 24, 2019 to October 25, 2019
| Minneapolis, MN This workshop will provide participants with a road-map and practical applications to successfully navigate the many potential reimbursement pitfalls. After an overview of current reimbursement... Read More
November
06
November 6, 2019 | Arlington, VA
The AdvaMed Cybersecurity Summit brings together experts across the device security spectrum. Experts will provide in-depth and timely updates on the state of medical device cybersecurity, including... Read More
November
07
November 7, 2019 | Arlington, VA
AdvaMed’s inaugural Health Data Stewardship & Privacy Summit will bring together leading experts and health care industry stakeholders to explore the current data privacy landscape and forecast... Read More
November
12
November 12, 2019 |
Check back soon for agenda and pricing information!
December
03
December 3, 2019 to December 4, 2019
| Washington, DC In this workshop, industry experts will provide an in-depth guide on how to secure regulatory approval in China. This unique opportunity will help you better understand China's approval process, from... Read More
Featured Video
Millions of lives are improved every day because of advancements in medical technology. We empower patients to share their experiences with medical technology and inspire patients across the globe. By raising our voices together, we are connecting with others who understand the value of medical technology and its life-changing impact. We are survivors. We are innovation. We are the story of medtech.
Industry News
Where Women Work
Prime employers for women BD and Medtronic both attended the prestigious MedTech Conference and addressed industry delegates.
The conference saw more than 3,300 of the world’s top medical technology executives gather in Boston, USA, for educational programming, valuable networking and business development opportunities.
Positioning corporate diversity and inclusion for success
BD’s VP of Inclusion & Diversity Johnel Evans joined other executive leaders on a panel discussing positioning...
Eight New York members of Congress are urging House and Senate leadership to address the Affordable Care Act's medical device tax before the end of the year.
The bipartisan group of lawmakers want to repeal or delay the excise tax, which was included in the 2010 health care law as a revenue generator. The 2.3% tax on the sale of medical devices took effect in 2013, but Congress acted in 2015 to impose a two-year moratorium. In 2017, Congress extended the moratorium on the medical device tax...
NEW YORK, Sept. 18, 2019 /PRNewswire/ -- TEAMFund ("Transforming Equity and Access for MedTech") -- a novel hybrid organization combining a Non-Profit with a For-Profit Fund investing in medical technology companies that improve patient access in low-resource settings -- today announced the Final Closing of its $30mm Inaugural Fund.
The Fund is led by longtime MedTech investor, Yousuf Mazhar and Tim Ring, former Chairman and CEO of C.R. Bard. TEAMFund was the inspiration of Ms. Kathryn Gleason...
BOSTON--(BUSINESS WIRE)--ApiFix Ltd., a leading motion-preservation scoliosis correction company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) via a Humanitarian Device Exemption (HDE) to market the Minimally Invasive Deformity Correction (MID-C) system for the treatment of progressive adolescent idiopathic scoliosis (AIS).
AIS is the most common type of scoliosis with no identifiable cause and affects 2%-3% of children between ages 10 to 21....
LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month program, featuring leading-edge device, diagnostic, and digital health technologies from around the world. These best-in-class startups will receive unparalleled visibility and access to leading manufacturers, providers, investors, and other industry stakeholders.
“We take great...
Twitter Feed
October 23, 2019 - 1:02pm
Some current regulations unnecessarily limit how health care providers can coordinate care for patients in partners… https://t.co/Lqj8Nn4pYL
October 23, 2019 - 12:02pm
“Medical devices diagnosed me. The cancer in my second breast would not have even been diagnosed without the MRI.”… https://t.co/1kZm6tf0TX